Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease [Phase 3]
Phase 3 trial results for once-daily oral orforglipron (LY3502970) in Japanese adults with obesity have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Does What You Eat Affect Your Brain [NA]
Completed clinical trial assessing how dietary factors influence brain-related conditions, with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities [Phase 1]
Phase 1 study results for LY3502970 in Chinese participants with overweight or obesity and weight-related comorbidities have been completed.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight [Phase 1]
Phase 1 trial comparing tablet and capsule forms of Orforglipron (LY3502970) in healthy overweight/obese participants; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-14Clinical Trial Results: H-PACE Program for the Improvement of Lifestyle Behaviors Among Children [NA]
Completed clinical trial evaluating the H-PACE program for improving lifestyle behaviors in children with pediatric obesity; results availab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants [Phase 1]
Phase 1 multiple-dose study of LY3502970 in healthy overweight/obese participants completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Update: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) [Phase 3]
A Phase 3 cardiovascular outcomes trial evaluating the safety of Survodutide (BI 456906) in adults with overweight or obesity has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity [NA]
Completed clinical trial evaluating produce prescription programs for adults with overweight or obesity experiencing nutrition insecurity; r…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity [NA]
Pragmatic randomized clinical trial evaluating strategies to limit weight gain in pregnancy and prevent obesity postpartum.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Laparoscopic TAP Block for Sleeve Gastrectomy: Does Timing Matter [NA]
A completed clinical trial investigated the timing of laparoscopic TAP block for sleeve gastrectomy and its effect on postoperative pain out…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Impact of Dietary Fiber as Prebiotics on Intestinal Microbiota in Obese Thai Children [NA]
Completed clinical trial studying the impact of dietary fiber as prebiotics on intestinal microbiota in obese Thai children.
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: Enhancing BodyWorks: A Canine Health Literacy Module [NA]
Clinical trial results for a canine health literacy module are posted; study completed with overweight and obesity conditions among adolesce…
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Update: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) [Phase 3]
Phase 3 cardiovascular safety trial evaluating survodutide (BI 456906) in adults with overweight or obesity is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Clinical trial results for early GLP-1 receptor agonist and SGLT2 inhibitor add-on strategies in adults with obesity, type 2 diabetes, cardi…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Update: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight [Phase 3]
Phase 3 trial update evaluating Survodutide (BI 456906) for weight loss in people with overweight/obesity and type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]
Phase 2 trial results for LY3841136 versus placebo in adults with obesity or overweight have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]
Phase 3 trial investigating ixekizumab given with tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight; …
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes [NA]
A completed clinical trial evaluating tolerability, acceptance, and utility of intermittent continuous glucose monitoring (CGM) use in youth…
-
CLINICAL_TRIALS trial_result · 2026-06-11Clinical Trial Update: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) [Phase 3]
A Phase 3 cardiovascular outcome trial evaluating the safety of Survodutide (BI 456906) in adults with overweight or obesity is active/not r…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight [Phase 3]
Phase 3 trial update for retatrutide (LY3437943) in participants without type 2 diabetes who have obesity or overweight; study status is act…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 trial update for HS-20094 in Chinese adults with overweight or obesity has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix [Phase 3]
A Phase 3 trial assessing lifestyle interventions for expectant mothers (LIFE-Moms Phoenix) completed, evaluating effects on obesity-related…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Effect of Obesity on Proton Pump Inhibitors [Phase 4]
Phase 4 trial assessing the effect of obesity on proton pump inhibitors in pediatric obesity and NAFLD with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) [Phase 3]
Phase 3 trial update for orforglipron (ATTAIN-MAINTAIN) evaluating maintenance of body weight reduction in adults with obesity or overweight…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 clinical trial update for HS-20094 in Chinese adults with overweight or obesity has completed recruitment.